4D Molecular Therapeutics, Inc.
FDMT- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650648
近 90 天，4D Molecular Therapeutics, Inc. 內部人申報 0 筆公開市場買進、7 筆賣出；2026 年第 2 季末有 157 家機構在 13F 申報持有，市值合計 $7.71 億；沒有大師持有。
SEC 申報
4D Molecular Therapeutics, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F，最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀；8-K 的新聞稿等附件（例如 Item 2.02 的 EX-99.1）在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/12 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/11/12 | 8-K | 2.029.01 | 2026/11/12 | SEC | 目錄 |
| 2026/9/28 | 8-K | 8.01 | 2026/9/28 | SEC | 目錄 |
| 2026/8/13 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/13 | 8-K | 2.02 | 2026/8/13 | SEC | 目錄 |
| 2026/7/20 | 8-K | 8.01 | 2026/7/18 | SEC | 目錄 |
| 2026/6/29 | 8-K | 1.012.03 | 2026/6/24 | SEC | 目錄 |
| 2026/6/22 | 8-K | 5.07 | 2026/6/17 | SEC | 目錄 |
| 2026/5/7 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/7 | 8-K | 2.029.01 | 2026/5/7 | SEC | 目錄 |
| 2026/3/30 | 8-K | 5.02 | 2026/3/25 | SEC | 目錄 |
| 2026/3/18 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/3/18 | 8-K | 2.029.01 | 2026/3/18 | SEC | 目錄 |
| 2026/1/26 | 8-K | 3.029.01 | 2026/1/22 | SEC | 目錄 |
| 2026/1/7 | 8-K | 2.025.02 | 2025/12/31 | SEC | 目錄 |
| 2025/12/10 | 8-K | 8.01 | 2025/12/10 | SEC | 目錄 |
| 2025/11/17 | 8-K | 5.02 | 2025/11/17 | SEC | 目錄 |
| 2025/11/10 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/10 | 8-K | 2.029.01 | 2025/11/10 | SEC | 目錄 |
| 2025/11/7 | 8-K | 8.019.01 | 2025/11/6 | SEC | 目錄 |
| 2025/11/6 | 8-K | 2.028.01 | 2025/11/6 | SEC | 目錄 |
| 2025/10/31 | 8-K | 1.01 | 2025/10/31 | SEC | 目錄 |
| 2025/10/2 | 8-K | 5.025.039.01 | 2025/9/30 | SEC | 目錄 |
| 2025/8/11 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/11 | 8-K | 2.029.01 | 2025/8/11 | SEC | 目錄 |
| 2025/7/2 | 8-K | 5.028.01 | 2025/6/27 | SEC | 目錄 |
| 2025/6/20 | 8-K | 5.07 | 2025/6/17 | SEC | 目錄 |
| 2025/5/8 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/8 | 8-K | 2.029.01 | 2025/5/8 | SEC | 目錄 |
| 2025/2/28 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/2/28 | 8-K | 2.029.01 | 2025/2/28 | SEC | 目錄 |
| 2025/2/10 | 8-K | 8.01 | 2025/2/8 | SEC | 目錄 |
| 2025/1/10 | 8-K | 2.028.019.01 | 2025/1/10 | SEC | 目錄 |
| 2024/12/11 | 8-K | 3.029.01 | 2024/12/6 | SEC | 目錄 |
| 2024/11/13 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/13 | 8-K | 2.029.01 | 2024/11/13 | SEC | 目錄 |
| 2024/9/18 | 8-K | 8.01 | 2024/9/18 | SEC | 目錄 |
| 2024/8/8 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/8 | 8-K | 2.029.01 | 2024/8/8 | SEC | 目錄 |
| 2024/7/23 | 8-K | 7.01 | 2024/7/23 | SEC | 目錄 |
| 2024/7/17 | 8-K | 8.01 | 2024/7/17 | SEC | 目錄 |
| 2024/6/7 | 8-K | 1.019.01 | 2024/6/7 | SEC | 目錄 |
| 2024/5/24 | 8-K | 5.07 | 2024/5/21 | SEC | 目錄 |
| 2024/5/9 | 8-K | 2.029.01 | 2024/5/9 | SEC | 目錄 |
| 2024/5/9 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/2/29 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/2/29 | 8-K | 2.029.01 | 2024/2/29 | SEC | 目錄 |
| 2024/2/9 | 8-K | 8.019.01 | 2024/2/6 | SEC | 目錄 |
| 2024/1/4 | 8-K | 5.02 | 2024/1/1 | SEC | 目錄 |
| 2023/11/22 | 8-K | 5.039.01 | 2023/11/16 | SEC | 目錄 |